BI Afatinib Trial

About this trial

Patient Profile

Recurrent/refractory neuroectodermal tumours, rhabdomyosarcoma and/or other solid tumours with known ErbB pathway deregulation regardless of tumour histology

Where’s this trial being run?

Crumlin Children’s Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information


Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: BI Afatinib Trial
Number: CTRIAL-IE 18-23
Full Title:

Phase I/II open label, dose escalation trial to determine the MTD, safety, PK and efficacy of afatinib monotherapy in children aged ≥1 year to

Principal Investigator: Cormac Owens
Type: Industry Sponsored
Recruitment Started: Global:
Global Recruitment Target:
Ireland Recruitment Target: